Izuru Masuda

3.0k total citations
77 papers, 1.8k citations indexed

About

Izuru Masuda is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Izuru Masuda has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Izuru Masuda's work include Cardiac Fibrosis and Remodeling (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Cardiac Imaging and Diagnostics (7 papers). Izuru Masuda is often cited by papers focused on Cardiac Fibrosis and Remodeling (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Cardiac Imaging and Diagnostics (7 papers). Izuru Masuda collaborates with scholars based in Japan, United States and United Kingdom. Izuru Masuda's co-authors include Kazuwa Nakao, Yoshihiko Saito, Yoshihiro Miyamoto, Koichiro Kuwahara, Emiko Ogawa, Hiroshi Itoh, Yoshihiro Ogawa, Masaki Harada, Takaaki Yoshimasa and Osamu Nakagawa and has published in prestigious journals such as Circulation, PLoS ONE and Circulation Research.

In The Last Decade

Izuru Masuda

76 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Izuru Masuda Japan 22 1.1k 422 350 249 218 77 1.8k
Ragavendra R. Baliga United States 17 850 0.8× 585 1.4× 222 0.6× 197 0.8× 295 1.4× 54 1.6k
Lidia Staszewsky Italy 28 1.6k 1.5× 623 1.5× 444 1.3× 252 1.0× 91 0.4× 78 2.7k
Toshimitsu Nozaki Japan 14 869 0.8× 335 0.8× 313 0.9× 127 0.5× 137 0.6× 23 1.6k
Lisa C. Costello‐Boerrigter United States 24 1.7k 1.5× 451 1.1× 326 0.9× 539 2.2× 193 0.9× 59 2.3k
Włodzimierz J. Musiał Poland 22 877 0.8× 420 1.0× 434 1.2× 264 1.1× 88 0.4× 146 2.0k
Marcin Gruchała Poland 20 750 0.7× 728 1.7× 492 1.4× 157 0.6× 359 1.6× 153 2.0k
Guido Boerrigter United States 30 1.8k 1.6× 758 1.8× 336 1.0× 551 2.2× 219 1.0× 77 2.7k
Stephan H. Schirmer Germany 28 1.4k 1.3× 523 1.2× 543 1.6× 190 0.8× 107 0.5× 82 2.4k
Nauder Faraday United States 27 1.5k 1.3× 356 0.8× 653 1.9× 326 1.3× 101 0.5× 79 2.8k
Masashi Fujita Japan 19 1.0k 0.9× 473 1.1× 391 1.1× 133 0.5× 125 0.6× 62 2.0k

Countries citing papers authored by Izuru Masuda

Since Specialization
Citations

This map shows the geographic impact of Izuru Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izuru Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izuru Masuda more than expected).

Fields of papers citing papers by Izuru Masuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izuru Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izuru Masuda. The network helps show where Izuru Masuda may publish in the future.

Co-authorship network of co-authors of Izuru Masuda

This figure shows the co-authorship network connecting the top 25 collaborators of Izuru Masuda. A scholar is included among the top collaborators of Izuru Masuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izuru Masuda. Izuru Masuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanabe, Naoya, Hiroaki Iijima, Ryo Sakamoto, et al.. (2024). Centrilobular emphysema and airway dysanapsis: factors associated with low respiratory function in younger smokers. ERJ Open Research. 10(2). 695–2023. 3 indexed citations
2.
Motoki, Hirohiko, Yoshito Inobe, Toshiki Fukui, et al.. (2023). Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetes Mellitus Undergoing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors (EAGLE-DH). Advances in Therapy. 40(11). 5055–5075. 11 indexed citations
3.
Tanabe, Naoya, Yusuke Shiraishi, Hiroshi Shima, et al.. (2023). Centrilobular Emphysema Is Associated with Pectoralis Muscle Reduction in Current Smokers without Airflow Limitation. Respiration. 102(3). 194–202. 7 indexed citations
4.
Yamamoto, Ryohei, Tomoya Ueda, Satomi Ishihara, et al.. (2023). Derivation and validation of a clinical predictive model of NT-proBNP ≥125 pg/mL to detect pre-heart failure. Journal of Cardiology. 82(6). 481–489. 3 indexed citations
5.
Tanabe, Naoya, Izuru Masuda, Yusuke Shiraishi, et al.. (2022). Clinical relevance of multiple confirmed preserved ratio impaired spirometry cases in adults. Respiratory Investigation. 60(6). 822–830. 7 indexed citations
6.
Matsumoto, Chisa, Hisao Ogawa, Yoshihiko Saito, et al.. (2022). Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus. BMJ Open Diabetes Research & Care. 10(2). e002745–e002745. 4 indexed citations
7.
Tanabe, Naoya, Yusuke Shiraishi, Hiroshi Shima, et al.. (2022). Physiological impacts of computed tomography airway dysanapsis, fractal dimension, and branch count in asymptomatic never smokers. Journal of Applied Physiology. 134(1). 20–27. 16 indexed citations
8.
Tanabe, Naoya, Hiroaki Iijima, Yusuke Shiraishi, et al.. (2022). Early chronic obstructive pulmonary disease: Associations of two spirometry criteria with clinical features. Respiratory Medicine. 204. 107011–107011. 3 indexed citations
9.
Segawa, Hiroyoshi, Akane Higashi, Izuru Masuda, et al.. (2021). Urinary sodium/potassium ratio as a screening tool for hyperaldosteronism in men with hypertension. Hypertension Research. 44(9). 1129–1137. 8 indexed citations
10.
Okada, Sadanori, Takeshi Morimoto, Hisao Ogawa, et al.. (2020). Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes. Journal of General Internal Medicine. 36(3). 632–639. 7 indexed citations
11.
Yamamoto, Hiroko, Toshiki Nakajima, Shuichiro Nakabo, et al.. (2019). Evaluation of risk factors for atherosclerosis using carotid ultrasonography in Japanese patients with rheumatoid arthritis. International Journal of Rheumatic Diseases. 22(7). 1312–1318. 4 indexed citations
12.
Soejima, Hirofumi, Hisao Ogawa, Takeshi Morimoto, et al.. (2019). Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients. Journal of Cardiology. 75(4). 387–393. 4 indexed citations
13.
Hashimoto, Motomu, Hiroko Yamamoto, Masao Tanaka, et al.. (2018). Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study. Rheumatology International. 38(9). 1679–1689. 15 indexed citations
14.
Matsumoto, Chisa, Hisao Ogawa, Yoshihiko Saito, et al.. (2018). Abstract 15399: The Association of Visit-To-Visit Blood Pressure and Blood Glucose Variability and Incidence of Dementia in Patients With Type 2 Diabetes Mellitus: Insights From the Jpad2 Cohort Study. Circulation. 1 indexed citations
15.
Saito, Yoshihiko, Sadanori Okada, Hisao Ogawa, et al.. (2016). Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus. Circulation. 135(7). 659–670. 89 indexed citations
16.
Daida, Hiroyuki, Ryuji Nohara, Mitsumasa Hata, et al.. (2014). Can Intensive Lipid-Lowering Therapy Improve the Carotid Intima-Media Thickness in Japanese Subjects Under Primary Prevention for Cardiovascular Disease?: The JART and JART Extension Subanalysis. Journal of Atherosclerosis and Thrombosis. 21(7). 739–754. 8 indexed citations
17.
Nishikimi, Toshio, Hiroyuki Okamoto, Masahiro Nakamura, et al.. (2013). Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart Failure. PLoS ONE. 8(1). e53233–e53233. 50 indexed citations
18.
Kurabayashi, Masahiko, Ichiro Sakuma, Ryuzo Kawamori, et al.. (2010). Can Intensive Lipid-Lowering Therapy with Statins Ameliorate Atherosclerosis in Japanese Patients?. Journal of Atherosclerosis and Thrombosis. 17(4). 416–422. 6 indexed citations
19.
Miyamoto, Yoshihiro, Yoshihiko Saito, Noboru Kajiyama, et al.. (1998). IS040 Positive association between essential hypertension and Glu298Asp polymorphism in the endothelial nitric oxide synthase gene. Japanese Circulation Journal-english Edition. 62. 25. 1 indexed citations
20.
Shimizu, Mitsuyuki, Izuru Masuda, Tomoko Nakano, et al.. (1988). Abnormal polyamine metabolism in hypertensive cardiac hypertrophy.. Japanese Circulation Journal. 52(10). 1209–1215. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026